[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.168.204. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 597
Citations 0
Comment & Response
November 3, 2015

Use of Implantable Cardioverter-Defibrillators Among Medicare Patients

Author Affiliations
  • 1Section of Geriatric Cardiology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania
  • 2Columbia University Medical Center, New York, New York
  • 3Washington University School of Medicine, St Louis, Missouri
JAMA. 2015;314(17):1873-1874. doi:10.1001/jama.2015.12212

To the Editor Dr Pokorney and colleagues1 described low (8.1%) use of implantable cardioverter-defibrillators (ICDs) in older patients with myocardial infarction (MI) who met criteria for implantation. They inferred that many older patients with MI not referred for ICDs might have benefited with significant prolongation of life. They also suggested that modifiable system factors contribute to ICD underuse.

First Page Preview View Large
First page PDF preview
First page PDF preview
×